September 16, 2018

FDA 503(A) Compounding of Bulk Substances Hearing Updates

Posted on16 Sep 2018

Tags503, 503(B), 505(A), Compounding, FDA, fda usp, MEDICATIONS

FDA 503(A) Compounding of Bulk Substances Hearing Updates In this PDF Dr. Anderson provides the latest status of the FDA actions around...

Products

#57 Prescription and management of anti-infective medications for chronic infectious disease $59.00
#56 Benzodiazepines $59.00
#55 Neurological Manifestations in Chronic Patients - Assessment and Management $59.00
Chronic Illness Interrelationships – Thinking and Management $59.00
HR1959 Preserving Patient Access to Compounded Medications Act of 2019 $0.00

Recent Articles

6A – 2019 IVC, Antioxidant – Chemo and Radiation Update
Adding Heparin to IV’s to Avoid Thrombosis
H.R. 1959 Preserving Patient Access to Compounded Medications Act of 2019
How can we use our failures to advance and adapt (in anything)? How can failure change medicine?
What are known cancer causes and what can I do about them?
An interview about “Outside the Box Cancer Thinking”
INTRAVENOUS AND INJECTION THERAPIES
Supplements for Cancer – Where do they fit in and what are some examples?
Food, Supplements, and Cancer
Outside the Box Cancer Therapies: CH 3,4

Pages

About Us
Testimonials
Contact
Privacy Policy
Terms of Use

There's still time to join Dr. Anderson on today's webcall @ 5:30PM PST!
#57 Prescription and management of anti-infective medications for chronic infectious disease.
Not a subscriber? Not a problem with our NEW on-demand option! Click HERE!
Dismiss